BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026

  October 21, 2026

   · 

  4 min read
• Press Releases

  AbbVie reaches agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for ELAHERE® in Platinum-Resistant Ovarian Cancer

  October 21, 2026

   · 

  6 min read
• Press Releases

  Nanoscope Therapeutics Announces Publication of Preclinical Data Showing Targeted, Durable Vision Restoration with OCT-Guided, Non-Viral Gene Delivery

  October 21, 2026

   · 

  5 min read
• Press Releases

  Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging

  October 21, 2026

   · 

  7 min read
• Press Releases

  Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting

  October 21, 2026

   · 

  13 min read
• Press Releases

  Sitryx to Participate in Upcoming November 2026 Investor Conferences

  October 21, 2026

   · 

  1 min read
• Press Releases

  United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026

  October 21, 2026

   · 

  2 min read
• Press Releases

  AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms

  October 21, 2026

   · 

  1 min read
• Press Releases

  Foundation Medicine and Joint Collaborators to Present 12 Abstracts at the ESMO Congress 2026

  October 21, 2026

   · 

  8 min read
• Press Releases

  Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™

  October 21, 2026

   · 

  7 min read